Encompass Health Corporation has reiterated its financial outlook for the full year 2025. The company forecasts net operating revenue between $5,850 million and $5,925 million. Adjusted EBITDA is expected to range from $1,185 million to $1,220 million. Additionally, the company projects adjusted earnings per share from continuing operations attributable to Encompass Health to be between $4.85 and $5.10. The company has refrained from providing guidance on a GAAP basis, except for net operating revenues, due to the unpredictability of certain external factors that could impact its financial results. These include various settlements, professional fees, and other items not indicative of ongoing performance. However, for 2025, Encompass Health estimates interest expense and amortization of debt discounts and fees to be approximately $125 million, and amortization of debt-related items to be around $10 million. Members of the company's senior management team are scheduled to meet with investors and analysts in June 2025 to discuss these projections.